Drug development for glioma: are we repeating the same mistakes?

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)10-12
Number of pages3
JournalThe Lancet Oncology
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Glioma
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology

Cite this

@article{34d7ed1011ac421280626be74b19eb3e,
title = "Drug development for glioma: are we repeating the same mistakes?",
author = "Roger Stupp",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/S1470-2045(18)30827-1",
language = "English (US)",
volume = "20",
pages = "10--12",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

Drug development for glioma : are we repeating the same mistakes? / Stupp, Roger.

In: The Lancet Oncology, Vol. 20, No. 1, 01.01.2019, p. 10-12.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Drug development for glioma

T2 - are we repeating the same mistakes?

AU - Stupp, Roger

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85059497981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059497981&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30827-1

DO - 10.1016/S1470-2045(18)30827-1

M3 - Comment/debate

VL - 20

SP - 10

EP - 12

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 1

ER -